The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
So we so the name got changed in 2014. Okay. 2014, a bunch of people got in a room and they said, "You know what? This bulb vaginal atrophy thing, that's kind of a bad name because it doesn't describe what's really happening to people." So, they changed the name to Genital urinary syndrome of menopause, GSM.
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.